Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01497405 · ClinicalTrials.gov registry record · Phase 1
WHC+ (Women's Health CoOp PLUS)
A Phase 1 study, sponsored by RTI International.
- Completed
- Registry status
- Phase 1
- Development phase
- 641
- Enrollment target
NCT01497405 is a Phase 1 study that has completed, run by RTI International. The registered enrollment target is 641 participants.
The verdict
NCT01497405, a Phase 1 study, has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 641 participants
- Enrollment target
Study Summary
This study compares the effects of standard HIV test, treat and retain (TTR) practices with TTR plus a woman-focused enhanced strategy--Women's Health CoOp (WHC+) intervention) targeting hard-to-reach and vulnerable alcohol and other drug (AOD)-using women to determine if the WHC+ intervention is more efficacious than TTR alone in reducing HIV risk behavior. Additionally, the study will determine whether HIV positive women in the WHC+ arm are more likely to follow through with referrals for further medical evaluation and linkages to HIV treatment and other care than women in the TTR arm.
Interventions
- BEHAVIORAL Test, Treat, Retain(TTR) + Women's Health CoOp (WHC)
- BIOLOGICAL Test, Treat, Retain(TTR) only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 641 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01497405
The ClinicalTrials.gov registry entry for NCT01497405 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 641 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Test, Treat, Retain(TTR) + Women's Health CoOp (WHC) is the first listed.
NCT01497405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01497405 about?
NCT01497405 is a clinical study titled "WHC+ (Women's Health CoOp PLUS)". This study compares the effects of standard HIV test, treat and retain (TTR) practices with TTR plus a woman-focused enhanced strategy--Women's Health CoOp (WHC+) intervention) targeting hard-to-reach and vulnerable alcohol and other drug (AOD)-using women to determine if the WHC+ intervention is mo...
What is the current status of trial NCT01497405?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 641 participants. The study started on 2012-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01497405?
The interventions under investigation include: Test, Treat, Retain(TTR) + Women's Health CoOp (WHC) (BEHAVIORAL), Test, Treat, Retain(TTR) only (BIOLOGICAL).
Who is sponsoring clinical trial NCT01497405?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.